Agreed if a patient or physician saw this they would be interested. Similarly big pharma ought to find it interesting- because it is very promising research
BUT the people who count, for the most part, were contacted months ago by Bertolino and leo, as they checked in with big pharma about the B UP trial, and pitched the notion of a pill for IBD as well
Unless IPIX execs have been asleep or hibernating or something
Market Data 
Markets 
AI
